Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired Pneumonia
Clinical trial NCT00707239 · TERMINATED
Trial details
- NCT number
- NCT00707239
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2011-06-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.